AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology
Repeated immunization with AFFITOPE® peptide active immunotherapy candidates AT04A and AT06A is safe, well-tolerated and…
OpenEnvoy Launches Ask OE to Solve Enterprise Finance AI’s Foundational Problem
Fortinet launches Singapore NDR cloud PoP to strengthen threat detection across ASEAN